Results May Vary: Individual results will vary based on factors including age, baseline health condition, starting weight, BMI, metabolic factors, consistency of use, genetic factors, current medications, lifestyle choices, dietary habits, physical activity level, and other individual variables
*Compounded medications offered through this service are prescribed on an individual basis by licensed healthcare While some patients may experience weight loss or other benefits, results are not guaranteed
The market is projected to record a CAGR of 17.7% from 2026 to 2033
One Targeted Solution
Side Effects of Each Medication Both medications can cause specific side effects, and understanding these side effects can help you make an informed decision: Common Side Effects for Both Nausea (most common, especially when starting) Vomiting Diarrhea Constipation Stomach pain Fatigue Headache Semaglutide-Specific Side Effects Nausea affects about 44% of users initially Side effects typically improve after 4-8 weeks Injection site reactions are rare Tirzepatide-Specific Side Effects Nausea affects about 12-18% of users (lower than Semaglutide) May cause more digestive upset initially Some patients report better tolerance overall Most side effects are temporary and resolve as your body adjusts to the medication
Starting July 1, 2026, Medicare Part D covers Wegovy (semaglutide) for weight loss under the GLP-1 Bridge at a $50 monthly copay
